Supports postdoctoral researchers developing innovative translational medicine projects that bridge basic science and clinical applications with a focus on human relevance and clinical collaboration.
Funder: PhRMA Foundation
Due Dates: May 27, 2026 (Letter of Intent) | November 18, 2026 (Full application, by invitation)
Funding Amounts: $60,000/year for up to 2 years; stipend only; 12, 18, or 24 months duration
Summary: Supports postdoctoral researchers at U.S. universities conducting multidisciplinary translational medicine research bridging discoveries to clinical applications.
Key Information: Applicants must have a doctorate awarded after Jan 1, 2024 and at least two first-author publications.
This fellowship provides stipend support for postdoctoral researchers working at accredited U.S. universities on projects in translational medicine. The program is designed to bridge basic scientific discoveries and their application in clinical settings, with a focus on addressing unmet clinical needs and fostering the development of innovative diagnostic, therapeutic, or computational tools to improve patient care. Proposals must emphasize human relevance, such as validation in human or human-relevant systems, precision medicine, or reducing reliance on animal testing. All projects must be hypothesis-driven and involve clinical collaboration.